Menopur is one of 12 small molecule programs targeting TIA. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
14 competitors in TIA
Taxotere
Calquence
Venclexta
Gazyva
Sequential
Tegafur-Gimeracil-Oteracil
BAY 987519
Apelin
Standard SPF 4 Sunscreen
Menopur
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources